“Upon entering my fellowship training, I became fascinated by lymphoma in particular, and have been especially intrigued too by how immunotherapy, especially CAR T cells, have improved outcomes for so many patients,” says Dr. Brian Sworder.
Researcher Spotlight
View All >Stanford University School of Medicine